Transplantation of Anergic Histoincompatible Bone Marrow Allografts

Eva C. Guinan(Dana-Farber Cancer Institute), John G. Gribben(Queen Mary University of London), Lee M. Nadler(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan)), Lisa Brennan(Harvard University), Naoto Hirano(University Health Network), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center)
New England Journal of Medicine
June 3, 1999
10.1056/nejm199906033402202
Cited by 435

Related Papers

PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
An immunogenic personal neoantigen vaccine for patients with melanoma
|Nature|2017|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k